Analysis of surgical tissues and peripheral blood before and after treatment showed that anti-CTLA-4 treatment could induce ICOS pathway activation, and CD4+ICOS+T cells could produce IFN-γ and recognize tumor antigens [103]. This evidence concerns the gene ICOS and neoplasm.